Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 15
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Batarfi K | 2021 | Blood.ca website | View ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Researchers | Clinical research |
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Bhalla A, Mukherjee M, Radford K, Nazy I, Kjarsgaard M, Bowdish DME, Nair P | 2021 | Allergy | View Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Health care providers | Basic research |
Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Al-Riyami AZ, Jug R, La Rocca U, Keshavarz H, Landry D, Shehata N, Stanworth SJ, Nahirniak S | 2021 | Transfusion | View Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Researchers | Benchmarking and standard setting |
Themed issue – focusing on donor assessment, motivation and vigilance | O’Brien SF, Ullum H, Seed CR | 2021 | Vox Sang | View Themed issue – focusing on donor assessment, motivation and vigilance | Researchers | New or improved product or process |
Adverse reactions reporting | Yan M | 2021 | Blood.ca website | View Adverse reactions reporting | Health care providers | Benchmarking and standard setting |
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Sun H, Yang M, Poon M-C, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S | 2021 | Haemophilia | View Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Researchers | Clinical research |
Challenging the 30-min rule for thawed plasma | Ramirez-Arcos S, Howell A, Bearne J, Bhakta V, Bower L, Cardigan R, Girard M, Kou Y, McDonald C, Nolin M-È, Sawicka D, Sheffield W | 2021 | Vox Sang | View Challenging the 30-min rule for thawed plasma | Researchers | Benchmarking and standard setting |
What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Lieberman L, Flegel W, Bodnar M, Clarke G, Hannon J | 2021 | CMAJ Open | View What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Health care providers | Benchmarking and standard setting |
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L, Land K, Townsend M, Jecko T, Rahimi-Levene N, Patidar G, Josephson CD, Arora S, Vermeulen M, Vrielink H, Montemayor C, Oreh A, Hindawi S, van den Berg K, Serrano K, So – Osman C, Wood E, Devine DV, Spitalnik SL, the ISBT COVID-19 Working Group | 2021 | Vox Sang | View ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Researchers | Clinical research |
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J | 2021 | Transfusion | View Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Stewart T | 2021 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Health care providers | Benchmarking and standard setting |
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Olasupo OO, Lowe MS, Krishan A, Collins P, Iorio A, Matino D | 2021 | Cochrane Database Syst Rev | View Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Health care providers | Clinical research |
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Grunau B, Asamoah-Boaheng M, Lavoie PM, Karim ME, Kirkham TL, Demers PA, Barakauskas V, Marquez AC, Jassem AN, O'Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM | 2021 | Clin Infect Dis | View A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Researchers | Clinical research |
Chapter 6: Donor selection, donor testing and pathogen reduction | Drews S, Khandelwal A, Goldman M, Devine D | 2021 | Clinical Guide to Transfusion | View Chapter 6: Donor selection, donor testing and pathogen reduction | Health care providers | Benchmarking and standard setting |
Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blake JT, McTaggart K, Couture C | 2021 | Transfusion | View Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blood operators | Benchmarking and standard setting |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
FcgammaRI and FcgammaRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia | Norris PAA, Segel GB, Burack WR, Sachs UJ, Lissenberg-Thunnissen SN, Vidarsson G, Bayat B, Cserti-Gazdewich CM, Callum J, Lin Y, Branch D, Kapur R, Semple JW, Lazarus AH | 2021 | Haematologica | View FcgammaRI and FcgammaRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia | Researchers | Basic research |
Pragmatic, double-blind, randomised trial evaluating the impact of red blood cell donor sex on recipient mortality in an academic hospital population: the innovative Trial Assessing Donor Sex (iTADS) protocol | Fergusson DA, Chassé M, Tinmouth A, Acker JP, English S, Forster AJ, Hawken S, Shehata N, Thavorn K, Wilson K, Tuttle A, Perelman I, Cober N, Maddison H, Tokessy M | 2021 | BMJ Open | View Pragmatic, double-blind, randomised trial evaluating the impact of red blood cell donor sex on recipient mortality in an academic hospital population: the innovative Trial Assessing Donor Sex (iTADS) protocol | Researchers | Clinical research |
DNA Mediated Blood Coagulation: Extracellular DNA Accelerates Fibrinogen Polymerization By Thrombin Independent of Contact Pathway | Vappala S, Straus S, Pryzdial EL, Conway E, Kizhakkedathu J | 2021 | Blood | View DNA Mediated Blood Coagulation: Extracellular DNA Accelerates Fibrinogen Polymerization By Thrombin Independent of Contact Pathway | Researchers | Basic research |
Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Schubert P, Johnson L, Culibrk B, Chen Z, Tan S, Marks DC, Devine DV | 2021 | Transfusion | View Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Researchers | New or improved product or process |
Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Modi D | 2021 | Ontario Regional Blood Coordinating Network December 2021 Newsletter | View Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Health care providers | Clinical research |
Corrigendum to "Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity" [J. Biotechnol. 208 (2015) 54-62] | Gierczak RF, Bhakta V, Xie M, Sheffield WP | 2020 | J Biotechnol | View Corrigendum to "Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity" [J. Biotechnol. 208 (2015) 54-62] | Researchers | Basic research |
Blood donors | Armstrong B, Reviewer for Second Edition: Goldman M | 2020 | ISBT Sci Ser | View Blood donors | Health care providers | Benchmarking and standard setting |
The Effect of Age and Type of Media on Growth Kinetics of Human Amniotic Fluid Stem cells | Borzou B, Mehrabani D, Zare S, Zamani-Pereshkaft M, Acker JP | 2020 | Biopreserv Biobank | View The Effect of Age and Type of Media on Growth Kinetics of Human Amniotic Fluid Stem cells | Researchers | Basic research |
HIT: still stringing us along | Warkentin TE | 2020 | Blood | View HIT: still stringing us along | Researchers | Clinical research |
MSM Research Program: Knowledge synthesis interim report | Walsh G, Haw J, Chargé S | 2020 | Blood.ca website | View MSM Research Program: Knowledge synthesis interim report | Other | Other |
Thrombospondin-1/CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells | Bissinger R, Petkova-Kirova P, Mykhailova O, Oldenborg P-A, Novikova E, Donkor DA, Dietz T, Bhuyan AAM, Sheffield WP, Grau M, Artunc F, Kaestner L, Acker JP, Qadri SM | 2020 | Cell Signal | View Thrombospondin-1/CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells | Researchers | Basic research |
Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study | Jackson Chornenki NL, James TE, Barty R, Liu Y, Rochwerg B, Heddle NM, Siegal DM | 2020 | Transfusion | View Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study | Health care providers | Clinical research |
Increased cytotoxic potential of CD8(+) T cells in immune thrombocytopenia | Vrbensky JR, Arnold DM, Kelton JG, Smith JW, Jaffer AM, Larché M, Clare R, Ivetic N, Nazy I | 2020 | Br J Haematol | View Increased cytotoxic potential of CD8(+) T cells in immune thrombocytopenia | Researchers | Basic research |
Pharmacy hydroxyurea education materials for patients with sickle cell disease: An environmental scan and assessment of accuracy | Cervi A, Diamantouros A, Azzam M, Lane SJ, Sapru H, Verhovsek M | 2020 | Pediatr Blood Cancer | View Pharmacy hydroxyurea education materials for patients with sickle cell disease: An environmental scan and assessment of accuracy | Researchers | Benchmarking and standard setting |
Acquired coagulation disorders | Warkentin T | 2020 | Oxford Textbook of Medicine, 6th edn | View Acquired coagulation disorders | Health care providers | Benchmarking and standard setting |
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty | Hwang SR, Wang Y, Weil EL, Padmanabhan A, Warkentin TE, Pruthi RK | 2020 | Platelets | View Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty | Health care providers | Clinical research |
Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives | Goyal S, Binnington B, McCarthy SDS, Desmaële D, Férrié L, Figadère B, Loiseau PM, Branch DR | 2020 | F1000Research | View Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives | Researchers | Basic research |
Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Leblanc J-F, Germain M, Delage G, O'Brien S, Drews SJ, Lewin A | 2020 | Transfusion | View Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Health care providers | Clinical research |
Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes | Lin BH, Sutherland MR, Rosell FI, Morrissey JH, Pryzdial ELG | 2020 | J Thromb Haemost | View Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes | Researchers | Basic research |
Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions | Minuk L, Clarke G, Lieberman L | 2020 | Can Fam Physician | View Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions | Health care providers | Clinical research |
Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Kjeldsen-Kragh J, Fergusson DA, Kjaer M, Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia HF, Landry D, Shehata N | 2020 | Blood Adv | View Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Health care providers | Clinical research |
L’exploration des frontières de l’hémolyse associée aux IgIV | Pendergrast J, Branch D | 2020 | Blood.ca website | View L’exploration des frontières de l’hémolyse associée aux IgIV | Health care providers | Benchmarking and standard setting |
Pre-transfusion Testing | Duncan J | 2020 | Clinical Guide to Transfusion | View Pre-transfusion Testing | Health care providers | Benchmarking and standard setting |
Stabilization of Lipid Membranes through Partitioning of the Blood Bag Plasticizer Di-2-ethylhexyl phthalate (DEHP) | Bider R-C, Lluka T, Himbert S, Khondker A, Qadri SM, Sheffield WP, Rheinstädter MC | 2020 | Langmuir | View Stabilization of Lipid Membranes through Partitioning of the Blood Bag Plasticizer Di-2-ethylhexyl phthalate (DEHP) | Researchers | Basic research |
Vox Sanguinis International Forum on Donor Incentives: Summary | Zeller MP, Ellingham D, Devine D, Lozano M, Lewis P, Zhiburt E, van der Linde L, Goldman M, Nakamura A, Inoue S, Takikawa M, Nakajima K, Turek P, Rehacek V, Sakashita AM, Kutner JM, Karim FA, Hindawi S, Jayasekara SBA, Merz EM, Gross S, Woimant G, Djoudi R, Byabazaire KD, Irving DO, Abdrakhmanova S, Khalykova A, Yilmaz S, Oruc NE, Huaynalaya IP, Ramirez LAS, Chuhriiev A | 2020 | Vox Sang | View Vox Sanguinis International Forum on Donor Incentives: Summary | Blood operators | Benchmarking and standard setting |
An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing | Wong RW, Balachandran A, Cheung PK, Cheng R, Pan Q, Stoilov P, Harrigan PR, Blencowe BJ, Branch DR, Cochrane A | 2020 | PLoS Pathog | View An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing | Researchers | Basic research |
HIV residual risk in Canada under a three-month deferral for men who have sex with men | O'Brien SF, Gregoire Y, Pillonel J, Steele WR, Custer B, Davison KL, Germain M, Lewin A, Seed CR | 2020 | Vox Sang | View HIV residual risk in Canada under a three-month deferral for men who have sex with men | Researchers | Other |
Blood System Inventory Management Best Practices Guide | Clarke G, Romans R | 2020 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Concentré de recherche: Estimation de la prévalence de l’hémophilie et de l’espérance de vie | Iorio A | 2020 | Blood.ca website | Health care providers | Clinical research | |
Effects of the COVID-19 pandemic on supply and use of blood for transfusion | Stanworth SJ, New HV, Apelseth TO, Brunskill S, Cardigan R, Doree C, Germain M, Goldman M, Massey E, Prati D, Shehata N, So-Osman C, Thachil J | 2020 | Lancet Haematol | View Effects of the COVID-19 pandemic on supply and use of blood for transfusion | Health care providers | Clinical research |
Mucosal versus systemic antibody responses to SARS-CoV-2 antigens in COVID-19 patients | Isho B, Abe KT, Zuo M, Jamal AJ, Rathod B, Wang JH, Li Z, Chao G, Rojas OL, Bang YM, Pu A, Christie-Holmes N, Gervais C, Ceccarelli D, Samavarchi-Tehrani P, Guvenc F, Budylowski P, Li A, Paterson A, Yun YF, Marin LM, Caldwell L, Wrana JL, Colwill K, Sicheri F, Mubareka S, Gray-Owen SD, Drews SJ, Siqueira WL, Barrios-Rodiles M, Ostrowski M, Rini JM, Durocher Y, McGeer AJ, Gommerman JL, Gingras A-C | 2020 | medRxiv | View Mucosal versus systemic antibody responses to SARS-CoV-2 antigens in COVID-19 patients | Researchers | Basic research |
Thrombotic Thrombocytopenic Purpura | Crowther M, Zawilska K, Mlynarski W, Arnold D | 2020 | McMaster Textbook of Internal Medicine | Health care providers | Benchmarking and standard setting | |
Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Shih AW, Morrison D, Sekhon AS, Lin Y, Charge S, Chipperfield K, Beaveridge J | 2020 | Transfusion | View Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Health care providers | Other |